Thornburg Investment Management’s GSK GSK Stock Holding History

Thornburg Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-312	Closed	-$16K	–	251
2017 Q1	$16K	Sell	312 -695,611	-100%	-$35.3M	﹤0.01%	254
2016 Q4	$33.5M	Sell	695,923 -73,402	-10%	-$3.63M	0.26%	77
2016 Q3	$41.5M	Sell	769,325 -51,003	-6%	-$2.8M	0.32%	67
2016 Q2	$44.4M	Buy	820,328 +536,227	+189%	+$28.2M	0.34%	63
2016 Q1	$14.4M	Buy	284,101 +6,534	+2%	+$325K	0.1%	168
2015 Q4	$14M	Sell	277,567 -9,041	-3%	-$461K	0.09%	184
2015 Q3	$13.8M	Sell	286,608 -3,082	-1%	-$160K	0.09%	177
2015 Q2	$15.1M	Sell	289,690 -647,354	-69%	-$36.4M	0.09%	190
2015 Q1	$54.1M	Buy	937,044 +720,810	+333%	+$41.3M	0.3%	87
2014 Q4	$11.6M	Sell	216,234 -59,792	-22%	-$3.35M	0.06%	221
2014 Q3	$15.9M	Buy	276,026 +44,528	+19%	+$2.73M	0.07%	209
2014 Q2	$15.5M	Buy	+231,498	New	+$15.7M	0.06%	207

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Thornburg Investment Management's GSK Position: Q2 2017 in Review

Thornburg Investment Management sold out of GSK (GSK) in Q2 2017, closing a stake of 312 shares — an estimated $16K sold.

Thornburg Investment Management first reported a position in GSK in Q2 2014 and held it in 12 quarters. The position peaked at $54.1M in Q1 2015. 780 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

Thornburg Investment Management reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
Thornburg Investment Management sold 312 GSK shares in Q2 2017, an estimated $16K.
Thornburg Investment Management first reported a position in GSK in Q2 2014 and held it in 12 quarters.
Thornburg Investment Management's GSK position peaked at $54.1M in Q1 2015.
780 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Thornburg Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.